Skip to main content
Erschienen in: Gastric Cancer 2/2019

01.03.2019 | Original Article

Risk factors for 30-day hospital readmission after radical gastrectomy: a single-center retrospective study

verfasst von: Raito Asaoka, Taiichi Kawamura, Rie Makuuchi, Tomoyuki Irino, Yutaka Tanizawa, Etsuro Bando, Masanori Terashima

Erschienen in: Gastric Cancer | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

Hospital readmission is gathering greater attention as a measure of health care quality. The introduction of fast-track surgery has led to shorter lengths of hospitalization without increasing the risk of postoperative complications and readmission. The collection of comprehensive readmission data is essential for the further improvement of patient care. The aim of the present study is to evaluate the risk factors for readmission within 30 days of discharge after gastrectomy.

Methods

A total of 1929 patients who underwent radical gastrectomy at Shizuoka Cancer Center were included in this study. A risk analysis with a stepwise logistic regression model was conducted to identify the risk factors for 30-day hospital readmission.

Results

The 30-day readmission rate was 2.70%. Common causes of readmission were an intolerance of oral intake and the presence of an intra-abdominal abscess. The C reactive protein (CRP) level on postoperative day (POD) 3 was significantly higher in the readmitted group; however, the other surgical outcomes, including the incidence of postoperative complications, did not differ to a statistically significant extent. The stepwise logistic regression analysis revealed that CRP on POD3 ≥ 12 mg/dl [odds ratio (OR) 2.08, 95% confidence interval (CI) 1.09–3.95, p = 0.025], laparoscopic surgery (OR 2.25, 95% CI 1.17–4.31, p = 0.015), and TG (OR 2.23, 95% CI 1.17–4.78, p = 0.023) were found to be independent risk factors for readmission.

Conclusions

CRP on POD3 ≥ 12 mg/dl, laparoscopic surgery, and TG were identified as independent risk factors for readmission.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Sugisawa N, Tokunaga M, Makuuchi R, Miki Y, Tanizawa Y, Bando E, et al. A phase II study of an enhanced recovery after surgery protocol in gastric cancer surgery. Gastric Cancer. 2016;19(3):961–7.CrossRefPubMed Sugisawa N, Tokunaga M, Makuuchi R, Miki Y, Tanizawa Y, Bando E, et al. A phase II study of an enhanced recovery after surgery protocol in gastric cancer surgery. Gastric Cancer. 2016;19(3):961–7.CrossRefPubMed
3.
Zurück zum Zitat Makuuchi R, Sugisawa N, Kaji S, Hikage M, Tokunaga M, Tanizawa Y, et al. Enhanced recovery after surgery for gastric cancer and an assessment of preoperative carbohydrate loading. Eur J Surg Oncol. 2017;43(1):210–7.CrossRefPubMed Makuuchi R, Sugisawa N, Kaji S, Hikage M, Tokunaga M, Tanizawa Y, et al. Enhanced recovery after surgery for gastric cancer and an assessment of preoperative carbohydrate loading. Eur J Surg Oncol. 2017;43(1):210–7.CrossRefPubMed
4.
Zurück zum Zitat Abdikarim I, Cao XY, Li SZ, Zhao YQ, Taupyk Y, Wang Q. Enhanced recovery after surgery with laparoscopic radical gastrectomy for stomach carcinomas. World J Gastroenterol. 2015;21(47):13339–44.CrossRefPubMedPubMedCentral Abdikarim I, Cao XY, Li SZ, Zhao YQ, Taupyk Y, Wang Q. Enhanced recovery after surgery with laparoscopic radical gastrectomy for stomach carcinomas. World J Gastroenterol. 2015;21(47):13339–44.CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Adamina M, Kehlet H, Tomlinson GA, Senagore AJ, Delaney CP. Enhanced recovery pathways optimize health outcomes and resource utilization: a meta-analysis of randomized controlled trials in colorectal surgery. Surgery. 2011;149(6):830–40.CrossRefPubMed Adamina M, Kehlet H, Tomlinson GA, Senagore AJ, Delaney CP. Enhanced recovery pathways optimize health outcomes and resource utilization: a meta-analysis of randomized controlled trials in colorectal surgery. Surgery. 2011;149(6):830–40.CrossRefPubMed
6.
Zurück zum Zitat Mastracci TM, Cohen Z, Senagore A, Members of the Evidence Based Reviews in Surgery G. Canadian Association of General Surgeons and American College of Surgeons Evidence-Based Reviews in Surgery. 24. Fast-track programs in colonic surgery. Systematic review of enhanced recovery programmes in colonic surgery. Can J Surg. 2008;51(1):70–2.PubMedPubMedCentral Mastracci TM, Cohen Z, Senagore A, Members of the Evidence Based Reviews in Surgery G. Canadian Association of General Surgeons and American College of Surgeons Evidence-Based Reviews in Surgery. 24. Fast-track programs in colonic surgery. Systematic review of enhanced recovery programmes in colonic surgery. Can J Surg. 2008;51(1):70–2.PubMedPubMedCentral
7.
Zurück zum Zitat Wang D, Kong Y, Zhong B, Zhou X, Zhou Y. Fast-track surgery improves postoperative recovery in patients with gastric cancer: a randomized comparison with conventional postoperative care. J Gastrointest Surg. 2010;14(4):620–7.CrossRefPubMed Wang D, Kong Y, Zhong B, Zhou X, Zhou Y. Fast-track surgery improves postoperative recovery in patients with gastric cancer: a randomized comparison with conventional postoperative care. J Gastrointest Surg. 2010;14(4):620–7.CrossRefPubMed
8.
Zurück zum Zitat Jencks SF, Williams MV, Coleman EA. Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med. 2009;360(14):1418–28.CrossRefPubMed Jencks SF, Williams MV, Coleman EA. Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med. 2009;360(14):1418–28.CrossRefPubMed
9.
Zurück zum Zitat Basse L, Thorbol JE, Lossl K, Kehlet H. Colonic surgery with accelerated rehabilitation or conventional care. Dis Colon Rectum. 2004;47(3):271–7 (discussion 7–8) CrossRefPubMed Basse L, Thorbol JE, Lossl K, Kehlet H. Colonic surgery with accelerated rehabilitation or conventional care. Dis Colon Rectum. 2004;47(3):271–7 (discussion 7–8) CrossRefPubMed
10.
Zurück zum Zitat Acher AW, Squires MH, Fields RC, Poultsides GA, Schmidt C, Votanopoulos KI, et al. Readmission following gastric cancer resection: risk factors and survival. J Gastrointest Surg. 2016;20(7):1284–94.CrossRefPubMed Acher AW, Squires MH, Fields RC, Poultsides GA, Schmidt C, Votanopoulos KI, et al. Readmission following gastric cancer resection: risk factors and survival. J Gastrointest Surg. 2016;20(7):1284–94.CrossRefPubMed
11.
Zurück zum Zitat Selby LV, Gennarelli RL, Schnorr GC, Solomon SB, Schattner MA, Elkin EB, et al. Association of hospital costs with complications following total gastrectomy for gastric adenocarcinoma. JAMA Surg. 2017;152(10):953–8.CrossRefPubMedPubMedCentral Selby LV, Gennarelli RL, Schnorr GC, Solomon SB, Schattner MA, Elkin EB, et al. Association of hospital costs with complications following total gastrectomy for gastric adenocarcinoma. JAMA Surg. 2017;152(10):953–8.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Ahmad R, Schmidt BH, Rattner DW, Mullen JT. Factors influencing readmission after curative gastrectomy for gastric cancer. J Am Coll Surg. 2014;218(6):1215–22.CrossRefPubMed Ahmad R, Schmidt BH, Rattner DW, Mullen JT. Factors influencing readmission after curative gastrectomy for gastric cancer. J Am Coll Surg. 2014;218(6):1215–22.CrossRefPubMed
13.
Zurück zum Zitat Schneider EB, Hyder O, Brooke BS, Efron J, Cameron JL, Edil BH, et al. Patient readmission and mortality after colorectal surgery for colon cancer: impact of length of stay relative to other clinical factors. J Am Coll Surg. 2012;214(4):390–8 (discussion 8–9).CrossRefPubMed Schneider EB, Hyder O, Brooke BS, Efron J, Cameron JL, Edil BH, et al. Patient readmission and mortality after colorectal surgery for colon cancer: impact of length of stay relative to other clinical factors. J Am Coll Surg. 2012;214(4):390–8 (discussion 8–9).CrossRefPubMed
14.
Zurück zum Zitat Merchant SJ, Ituarte PH, Choi A, Sun V, Chao J, Lee B, et al. Hospital readmission following surgery for gastric cancer: frequency, timing, etiologies, and survival. J Gastrointest Surg. 2015;19(10):1769–81.CrossRefPubMed Merchant SJ, Ituarte PH, Choi A, Sun V, Chao J, Lee B, et al. Hospital readmission following surgery for gastric cancer: frequency, timing, etiologies, and survival. J Gastrointest Surg. 2015;19(10):1769–81.CrossRefPubMed
15.
Zurück zum Zitat Jeong O, Kyu Park Y, Ran Jung M, Yeop Ryu S. Analysis of 30-day postdischarge morbidity and readmission after radical gastrectomy for gastric carcinoma: a single-center study of 2107 patients with prospective data. Medicine (Baltimore). 2015;94(11):e259.CrossRef Jeong O, Kyu Park Y, Ran Jung M, Yeop Ryu S. Analysis of 30-day postdischarge morbidity and readmission after radical gastrectomy for gastric carcinoma: a single-center study of 2107 patients with prospective data. Medicine (Baltimore). 2015;94(11):e259.CrossRef
16.
Zurück zum Zitat Japanese Gastric Cancer A. Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric Cancer. 2017;20(1):1–19.CrossRef Japanese Gastric Cancer A. Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric Cancer. 2017;20(1):1–19.CrossRef
17.
Zurück zum Zitat Honda M, Hiki N, Nunobe S, Ohashi M, Mine S, Watanabe M, et al. Unplanned admission after gastrectomy as a consequence of fast-track surgery: a comparative risk analysis. Gastric Cancer. 2016;19(3):1002–7.CrossRefPubMed Honda M, Hiki N, Nunobe S, Ohashi M, Mine S, Watanabe M, et al. Unplanned admission after gastrectomy as a consequence of fast-track surgery: a comparative risk analysis. Gastric Cancer. 2016;19(3):1002–7.CrossRefPubMed
18.
Zurück zum Zitat Nomura E, Lee SW, Tokuhara T, Nitta T, Kawai M, Uchiyama K. Functional outcomes according to the size of the gastric remnant and the type of reconstruction following distal gastrectomy for gastric cancer: an investigation including total gastrectomy. Jpn J Clin Oncol. 2013;43(12):1195–202.CrossRefPubMed Nomura E, Lee SW, Tokuhara T, Nitta T, Kawai M, Uchiyama K. Functional outcomes according to the size of the gastric remnant and the type of reconstruction following distal gastrectomy for gastric cancer: an investigation including total gastrectomy. Jpn J Clin Oncol. 2013;43(12):1195–202.CrossRefPubMed
19.
Zurück zum Zitat Nakane Y, Okumura S, Akehira K, Okamura S, Boku T, Okusa T, et al. Jejunal pouch reconstruction after total gastrectomy for cancer. A randomized controlled trial. Ann Surg. 1995;222(1):27–35.CrossRefPubMedPubMedCentral Nakane Y, Okumura S, Akehira K, Okamura S, Boku T, Okusa T, et al. Jejunal pouch reconstruction after total gastrectomy for cancer. A randomized controlled trial. Ann Surg. 1995;222(1):27–35.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Koizumi M, Hosoya Y, Dezaki K, Yada T, Hosoda H, Kangawa K, et al. Serum ghrelin levels partially recover with the recovery of appetite and food intake after total gastrectomy. Surg Today. 2014;44(11):2131–7.CrossRefPubMed Koizumi M, Hosoya Y, Dezaki K, Yada T, Hosoda H, Kangawa K, et al. Serum ghrelin levels partially recover with the recovery of appetite and food intake after total gastrectomy. Surg Today. 2014;44(11):2131–7.CrossRefPubMed
21.
Zurück zum Zitat Sriram K, Sulo S, VanDerBosch G, Partridge J, Feldstein J, Hegazi RA, et al. A comprehensive nutrition-focused quality improvement program reduces 30-day readmissions and length of stay in hospitalized patients. JPEN J Parenter Enteral Nutr. 2017;41(3):384–91.CrossRefPubMed Sriram K, Sulo S, VanDerBosch G, Partridge J, Feldstein J, Hegazi RA, et al. A comprehensive nutrition-focused quality improvement program reduces 30-day readmissions and length of stay in hospitalized patients. JPEN J Parenter Enteral Nutr. 2017;41(3):384–91.CrossRefPubMed
22.
Zurück zum Zitat Stratton RJ, Hebuterne X, Elia M. A systematic review and meta-analysis of the impact of oral nutritional supplements on hospital readmissions. Ageing Res Rev. 2013;12(4):884–97.CrossRefPubMed Stratton RJ, Hebuterne X, Elia M. A systematic review and meta-analysis of the impact of oral nutritional supplements on hospital readmissions. Ageing Res Rev. 2013;12(4):884–97.CrossRefPubMed
23.
Zurück zum Zitat Kim EY, Yim HW, Park CH, Song KY. C-reactive protein can be an early predictor of postoperative complications after gastrectomy for gastric cancer. Surg Endosc. 2017;31(1):445–54.CrossRefPubMed Kim EY, Yim HW, Park CH, Song KY. C-reactive protein can be an early predictor of postoperative complications after gastrectomy for gastric cancer. Surg Endosc. 2017;31(1):445–54.CrossRefPubMed
24.
Zurück zum Zitat Shishido Y, Fujitani K, Yamamoto K, Hirao M, Tsujinaka T, Sekimoto M. C-reactive protein on postoperative day 3 as a predictor of infectious complications following gastric cancer resection. Gastric Cancer. 2016;19(1):293–301.CrossRefPubMed Shishido Y, Fujitani K, Yamamoto K, Hirao M, Tsujinaka T, Sekimoto M. C-reactive protein on postoperative day 3 as a predictor of infectious complications following gastric cancer resection. Gastric Cancer. 2016;19(1):293–301.CrossRefPubMed
25.
Zurück zum Zitat Alazawi W, Pirmadjid N, Lahiri R, Bhattacharya S. Inflammatory and immune responses to surgery and their clinical impact. Ann Surg. 2016;264(1):73–80.CrossRefPubMed Alazawi W, Pirmadjid N, Lahiri R, Bhattacharya S. Inflammatory and immune responses to surgery and their clinical impact. Ann Surg. 2016;264(1):73–80.CrossRefPubMed
26.
Zurück zum Zitat Strong VE, Devaud N, Allen PJ, Gonen M, Brennan MF, Coit D. Laparoscopic versus open subtotal gastrectomy for adenocarcinoma: a case-control study. Ann Surg Oncol. 2009;16(6):1507–13.CrossRefPubMed Strong VE, Devaud N, Allen PJ, Gonen M, Brennan MF, Coit D. Laparoscopic versus open subtotal gastrectomy for adenocarcinoma: a case-control study. Ann Surg Oncol. 2009;16(6):1507–13.CrossRefPubMed
27.
Zurück zum Zitat Lu W, Gao J, Yang J, Zhang Y, Lv W, Mu J, et al. Long-term clinical outcomes of laparoscopy-assisted distal gastrectomy versus open distal gastrectomy for early gastric cancer: a comprehensive systematic review and meta-analysis of randomized control trials. Medicine (Baltimore). 2016;95(27):e3986.CrossRef Lu W, Gao J, Yang J, Zhang Y, Lv W, Mu J, et al. Long-term clinical outcomes of laparoscopy-assisted distal gastrectomy versus open distal gastrectomy for early gastric cancer: a comprehensive systematic review and meta-analysis of randomized control trials. Medicine (Baltimore). 2016;95(27):e3986.CrossRef
28.
Zurück zum Zitat Kim W, Kim HH, Han SU, Kim MC, Hyung WJ, Ryu SW, et al. Decreased morbidity of laparoscopic distal gastrectomy compared with open distal gastrectomy for stage I gastric cancer: short-term outcomes from a multicenter randomized controlled trial (KLASS-01). Ann Surg. 2016;263(1):28–35.CrossRefPubMed Kim W, Kim HH, Han SU, Kim MC, Hyung WJ, Ryu SW, et al. Decreased morbidity of laparoscopic distal gastrectomy compared with open distal gastrectomy for stage I gastric cancer: short-term outcomes from a multicenter randomized controlled trial (KLASS-01). Ann Surg. 2016;263(1):28–35.CrossRefPubMed
29.
Zurück zum Zitat Caruso S, Patriti A, Roviello F, De Franco L, Franceschini F, Ceccarelli G, et al. Robot-assisted laparoscopic vs open gastrectomy for gastric cancer: systematic review and meta-analysis. World J Clin Oncol. 2017;8(3):273–84.CrossRefPubMedPubMedCentral Caruso S, Patriti A, Roviello F, De Franco L, Franceschini F, Ceccarelli G, et al. Robot-assisted laparoscopic vs open gastrectomy for gastric cancer: systematic review and meta-analysis. World J Clin Oncol. 2017;8(3):273–84.CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Hiki N, Honda M, Etoh T, Yoshida K, Kodera Y, Kakeji Y, et al. Higher incidence of pancreatic fistula in laparoscopic gastrectomy. Real-world evidence from a nationwide prospective cohort study. Gastric Cancer. 2018;21(1):162–70.CrossRefPubMed Hiki N, Honda M, Etoh T, Yoshida K, Kodera Y, Kakeji Y, et al. Higher incidence of pancreatic fistula in laparoscopic gastrectomy. Real-world evidence from a nationwide prospective cohort study. Gastric Cancer. 2018;21(1):162–70.CrossRefPubMed
32.
Zurück zum Zitat Kazaure HS, Roman SA, Sosa JA. Association of postdischarge complications with reoperation and mortality in general surgery. Arch Surg. 2012;147(11):1000–7.CrossRefPubMed Kazaure HS, Roman SA, Sosa JA. Association of postdischarge complications with reoperation and mortality in general surgery. Arch Surg. 2012;147(11):1000–7.CrossRefPubMed
33.
Zurück zum Zitat Kohlnhofer BM, Tevis SE, Weber SM, Kennedy GD. Multiple complications and short length of stay are associated with postoperative readmissions. Am J Surg. 2014;207(4):449–56.CrossRefPubMedPubMedCentral Kohlnhofer BM, Tevis SE, Weber SM, Kennedy GD. Multiple complications and short length of stay are associated with postoperative readmissions. Am J Surg. 2014;207(4):449–56.CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Kelly KN, Iannuzzi JC, Aquina CT, Probst CP, Noyes K, Monson JR, et al. Timing of discharge: a key to understanding the reason for readmission after colorectal surgery. J Gastrointest Surg. 2015;19(3):418–27 (discussion 27–8).CrossRefPubMed Kelly KN, Iannuzzi JC, Aquina CT, Probst CP, Noyes K, Monson JR, et al. Timing of discharge: a key to understanding the reason for readmission after colorectal surgery. J Gastrointest Surg. 2015;19(3):418–27 (discussion 27–8).CrossRefPubMed
35.
Zurück zum Zitat Kelly KN, Iannuzzi JC, Rickles AS, Monson JR, Fleming FJ. Risk factors associated with 30-day postoperative readmissions in major gastrointestinal resections. J Gastrointest Surg. 2014;18(1):35–43 (discussion 4).CrossRefPubMed Kelly KN, Iannuzzi JC, Rickles AS, Monson JR, Fleming FJ. Risk factors associated with 30-day postoperative readmissions in major gastrointestinal resections. J Gastrointest Surg. 2014;18(1):35–43 (discussion 4).CrossRefPubMed
36.
Zurück zum Zitat Zhuang CL, Wang SL, Huang DD, Pang WY, Lou N, Chen BC, et al. Risk factors for hospital readmission after radical gastrectomy for gastric cancer: a prospective study. PLoS One. 2015;10(4):e0125572.CrossRefPubMedPubMedCentral Zhuang CL, Wang SL, Huang DD, Pang WY, Lou N, Chen BC, et al. Risk factors for hospital readmission after radical gastrectomy for gastric cancer: a prospective study. PLoS One. 2015;10(4):e0125572.CrossRefPubMedPubMedCentral
37.
Zurück zum Zitat Sundaram A, Srinivasan A, Baker S, Mittal SK. Readmission and risk factors for readmission following esophagectomy for esophageal cancer. J Gastrointest Surg. 2015;19(4):581–5 (discussion 6).CrossRefPubMed Sundaram A, Srinivasan A, Baker S, Mittal SK. Readmission and risk factors for readmission following esophagectomy for esophageal cancer. J Gastrointest Surg. 2015;19(4):581–5 (discussion 6).CrossRefPubMed
Metadaten
Titel
Risk factors for 30-day hospital readmission after radical gastrectomy: a single-center retrospective study
verfasst von
Raito Asaoka
Taiichi Kawamura
Rie Makuuchi
Tomoyuki Irino
Yutaka Tanizawa
Etsuro Bando
Masanori Terashima
Publikationsdatum
01.03.2019
Verlag
Springer Singapore
Erschienen in
Gastric Cancer / Ausgabe 2/2019
Print ISSN: 1436-3291
Elektronische ISSN: 1436-3305
DOI
https://doi.org/10.1007/s10120-018-0856-4

Weitere Artikel der Ausgabe 2/2019

Gastric Cancer 2/2019 Zur Ausgabe

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Recycling im OP – möglich, aber teuer

05.05.2024 DCK 2024 Kongressbericht

Auch wenn sich Krankenhäuser nachhaltig und grün geben – sie tragen aktuell erheblich zu den CO2-Emissionen bei und produzieren jede Menge Müll. Ein Pilotprojekt aus Bonn zeigt, dass viele Op.-Abfälle wiederverwertet werden können.

Im OP der Zukunft läuft nichts mehr ohne Kollege Roboter

04.05.2024 DCK 2024 Kongressbericht

Der OP in der Zukunft wird mit weniger Personal auskommen – nicht, weil die Technik das medizinische Fachpersonal verdrängt, sondern weil der Personalmangel es nötig macht.

Nur selten Nachblutungen nach Abszesstonsillektomie

03.05.2024 Tonsillektomie Nachrichten

In einer Metaanalyse von 18 Studien war die Rate von Nachblutungen nach einer Abszesstonsillektomie mit weniger als 7% recht niedrig. Nur rund 2% der Behandelten mussten nachoperiert werden. Die Therapie scheint damit recht sicher zu sein.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.